| Primary |
| Product Used For Unknown Indication |
39.0% |
| Drug Use For Unknown Indication |
19.7% |
| Breast Cancer |
5.2% |
| Dyspepsia |
5.2% |
| Gastrooesophageal Reflux Disease |
5.2% |
| Asthma |
3.5% |
| Premedication |
3.5% |
| Prophylaxis |
3.5% |
| Hypertension |
2.3% |
| Arthritis |
1.4% |
| Blood Cholesterol Increased |
1.4% |
| Gout |
1.4% |
| Abdominal Pain |
1.2% |
| Abdominal Pain Upper |
1.2% |
| Gastritis |
1.2% |
| Influenza Like Illness |
1.2% |
| Osteoporosis |
1.2% |
| Urticaria |
1.2% |
| Breast Cancer Metastatic |
0.9% |
| Cardiac Disorder |
0.9% |
|
| Urticaria |
14.5% |
| Neuropathy Peripheral |
10.5% |
| Tension |
6.6% |
| Anaphylactic Reaction |
5.3% |
| Hepatitis |
5.3% |
| Overdose |
5.3% |
| Vomiting |
5.3% |
| Anaphylactic Shock |
3.9% |
| Death |
3.9% |
| Drug Ineffective |
3.9% |
| Epilepsy |
3.9% |
| Jaundice |
3.9% |
| Pharmaceutical Product Complaint |
3.9% |
| Pyrexia |
3.9% |
| Rash |
3.9% |
| Sedation |
3.9% |
| Transient Ischaemic Attack |
3.9% |
| Aspartate Aminotransferase Increased |
2.6% |
| Chest Pain |
2.6% |
| Drug Interaction |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
28.9% |
| Drug Use For Unknown Indication |
18.7% |
| Ill-defined Disorder |
14.9% |
| Anaesthesia Procedure |
6.2% |
| Hypertension |
4.2% |
| Prophylaxis |
4.2% |
| Type 2 Diabetes Mellitus |
3.1% |
| Hyperemesis Gravidarum |
2.9% |
| Premedication |
2.7% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Breast Cancer Recurrent |
1.6% |
| Gastric Disorder |
1.3% |
| Hyperlipidaemia |
1.3% |
| Ulcer Haemorrhage |
1.3% |
| Breast Cancer Metastatic |
1.1% |
| Cerebrovascular Accident |
1.1% |
| Depression |
1.1% |
| Hiv Infection |
1.1% |
| Muscle Spasticity |
1.1% |
| Nausea |
1.1% |
|
| Rhabdomyolysis |
8.6% |
| Sudden Death |
8.6% |
| Completed Suicide |
6.9% |
| Hypoglycaemic Coma |
6.9% |
| White Blood Cell Count Decreased |
6.9% |
| Fatigue |
5.2% |
| Loss Of Consciousness |
5.2% |
| Pain |
5.2% |
| Stevens-johnson Syndrome |
5.2% |
| Unresponsive To Stimuli |
5.2% |
| Ventricular Tachycardia |
5.2% |
| Anaphylactic Shock |
3.4% |
| Atrioventricular Dissociation |
3.4% |
| Confusional State |
3.4% |
| Death |
3.4% |
| Erythema |
3.4% |
| Nasopharyngitis |
3.4% |
| Neutropenia |
3.4% |
| Pharmaceutical Product Complaint |
3.4% |
| Premature Baby |
3.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
29.8% |
| Rheumatoid Arthritis |
12.7% |
| Product Used For Unknown Indication |
12.2% |
| Hypertension |
6.0% |
| Prophylaxis |
5.7% |
| Pain |
3.5% |
| Hiv Infection |
3.0% |
| Premedication |
3.0% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Multiple Myeloma |
2.5% |
| Gastritis |
2.5% |
| Depression |
2.3% |
| Diabetes Mellitus |
2.0% |
| Aplastic Anaemia |
2.0% |
| Anxiety |
1.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Osteoporosis |
1.7% |
| Insomnia |
1.7% |
| Constipation |
1.6% |
| Nausea |
1.5% |
|
| Vomiting |
15.5% |
| Pneumothorax |
12.1% |
| Pneumonia |
9.3% |
| White Blood Cell Count Decreased |
7.3% |
| Weight Decreased |
5.9% |
| Vision Blurred |
5.1% |
| Nausea |
4.2% |
| Drug Ineffective |
4.0% |
| Pain |
3.7% |
| Sepsis |
3.4% |
| Weight Increased |
3.4% |
| Myocardial Infarction |
3.1% |
| Pulmonary Embolism |
3.1% |
| Pyrexia |
3.1% |
| Respiratory Failure |
3.1% |
| Death |
2.8% |
| Granulocytopenia |
2.8% |
| Incorrect Dose Administered |
2.8% |
| Injection Site Pain |
2.5% |
| Rash |
2.5% |
|
